Critical Updates in Treating Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia

Published: Oct. 23, 2020, 4 a.m.

Host: Keith S. Kaye, MD, MPH
Guest: Marin H. Kollef, MD, FACP, FCCP
Guest: Douglas N. Fish, PharmD

Hospital-acquired and ventilator-associated bacterial pneumonia, or HABP and VABP, increase the risk of prolonged hospitalization, morbidity, and mortality for critically ill patients. Dr. Marin Kollef and Dr. Keith Kaye discuss the role of newer antimicrobials and novel agents in treating HABP/VABP.